Sveriges mest populära poddar
Conversations in Drug Development
Hälsa och motionMedicin

Exploring Genome Editing Technologies in Drug Development

24 min•19 juni 2024

In this episode, host Dr. Katherine Bowen, is joined by Harriet Edwards, Associate Director in Regulatory Affairs, to explore the fascinating world of genome editing technologies. Together, they delve into the ethical considerations of editing somatic versus germline cells and trace the historical progression of these technologies from agriculture to healthcare. Join us as we discuss the complexity of genome editing methods, the irreversible nature of genetic changes, and the associated risks.

Fler avsnitt av Conversations in Drug Development

Visa alla avsnitt av Conversations in Drug Development
Live Biotherapeutics: Navigating the Next Frontier in Drug Development
•32 min
UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025
•26 min
How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?
•30 min
Navigating the FDA Landscape: More Changes, and What's Next?
•27 min
At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development
•40 min
Navigating the New FDA Landscape: Opportunities and Challenges Ahead
•36 min
From Lab to Launch – Avoiding the Pitfalls of Drug Development
•28 min
Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025
•33 min
How to Effectively De-Risk your IND Process
•53 min
Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators
•24 min

Conversations in Drug Development med Boyds finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.